Table 3.
PS‐Adjusted ORs (After Bonferroni Correction) for Each of the Considered Outcomes in the Whole Cohort for the Sensitivity Analysis
| Outcome | OR (95% CI) Before and During TAVI BAV (n=507) | OR (95% CI) Before and Not During TAVI BAV (n=197) | OR (95% CI) Not Before and During TAVI BAV (n=4466) |
|---|---|---|---|
| 30‐day mortality | 1.69 (0.79, 3.59) | 1.01 (0.29, 3.49) | 1.01 (0.59, 1.75) |
| MI | 1.13 (0.12, 10.32) | NA | 0.96 (0.22, 4.15) |
| Stroke | 0.79 (0.24, 2.60) | 0.57 (0.07, 4.80) | 0.88 (0.42, 1.82) |
| Moderate/severe AR/PVL | 1.60 (0.83, 3.07) | 0.93 (0.30, 2.89) | 1.28 (0.80, 2.06) |
| CAO | 0.23 (0.01, 8.94) | 0.61 (0.02, 23.89) | 0.81 (0.22, 2.94) |
| Valve dysfunction | 0.58 (0.19, 1.80) | 0.54 (0.06, 4.54) | 0.68 (0.34, 1.38) |
| Pacemaker implantation | 0.97 (0.50, 1.87) | 0.99 (0.39, 2.50) | 1.28 (0.86, 1.89) |
| Device migration | 1.54 (0.38, 6.23) | 1.10 (0.13, 9.74) | 1.16 (0.46, 2.91) |
| Dialysis | 1.02 (0.41, 2.53) | 0.98 (0.30, 3.23) | 0.91 (0.52, 1.58) |
| MVC | 0.66 (0.23, 1.90) | 0.82 (0.19, 3.47) | 0.83 (0.46, 1.50) |
| Early safety | 0.97 (0.62, 1.52) | 0.87 (0.43, 1.74) | 0.94 (0.71, 1.26) |
Note that the direct‐TAVI group was taken as the reference. AR indicates aortic regurgitation; BAV, balloon aortic valvuloplasty; CAO, coronary artery obstruction; MI, myocardial infarction; MVC, major vascular complication; NA, not applicable; ORs, odds ratios; PS, propensity score; PVL, paravalvular leakage; TAVI, transcatheter aortic valve implantation.